BANGALORE, India, April 5, 2022 /PRNewswire/ -- The Global Pharmacogenomics Market is Segmented by Type (Polymerase Chain Reaction (PCR), Microarray, Sequencing), by Application (Cardiovascular Diseases (CVD), Central Nervous System (CNS), Cancer/Oncology, Infectious Diseases): Opportunity Analysis and Industry Forecast, 2022-2028. It is published in Valuates Reports under the Pharmaceuticals & Biotech Category.
The global Pharmacogenomics (PGx) market size is projected to reach USD 14590 Million by 2028, from USD 7757.9 Million in 2021, at a CAGR of 9.3% during 2022-2028.
Major factors driving the growth of the Pharmacogenomics market are:
The Pharmacogenomics market is expected to grow as the focus on precision medicine grows, as does the need to improve drug safety and efficacy.
Furthermore, benefits such as more precise methods of determining appropriate drug dosages, better vaccines, and a reduction in overall healthcare costs are expected to propel the Pharmacogenomics market forward.
Get Your Sample Today: https://reports.valuates.com/request/sample/QYRE-Auto-22U5750/Global_Pharmacogenomics_PGx_Market
TRENDS INFLUENCING THE GROWTH OF PHARMACOGENOMICS MARKET
The Pharmacogenomics market is expected to grow as the focus on precision medicine grows. Pharmacogenomics holds the promise of one day being able to custom-make drugs for individuals based on their genetic makeup. Environment, diet, age, lifestyle, and state of health all have an impact on a person's response to medications, but understanding a person's genetic makeup is thought to be the key to developing personalized drugs that are more effective and safe. Precision medicines have also been shown to be effective in the treatment of cancer. Pharmacogenomics and related expertise are required for the development of such drugs.
Pharmacogenomics will allow for more accurate methods of determining appropriate drug dosages. This factor is expected to drive the growth of the pharmacogenomics market. Dosages based on a person's genetics, how well the body processes the medicine, and how long it takes to metabolize it will be replaced by dosages based on a person's genetics, how well the body processes the medicine, and how long it takes to metabolize it. This will increase the therapy's effectiveness while reducing the risk of overdosing.
Vaccines made of genetic material, such as DNA or RNA, promise all of the advantages of current vaccines without the risks. They will stimulate the immune system, but they will not be able to infect the body. They'll be low-cost, stable, and easy to store, and they'll be able to carry multiple pathogen strains at once. This in turn is expected to drive the growth of the pharmacogenomics market
A decrease in the overall cost of healthcare is expected to further drive the growth of the Pharmacogenomics market. Reduced adverse drug reactions, failed drug trials, the time it takes to get a drug approved, the length of time patients are on medication, the number of medications patients must take to find effective therapy, the effects of a disease on the body (through early detection), and an increase in the range of possible drug targets will all contribute to a net reduction in health-care costs.
Browse The Table Of Contents And List Of Figures At: https://reports.valuates.com/reports/QYRE-Auto-22U5750/global-pharmacogenomics-pgx
PHARMACOGENOMICS MARKET SHARE ANALYSIS
Based on type, the polymerase chain reaction is expected to have the largest market share. The polymerase chain reaction is expected to maintain its trend throughout the forecast period due to its irreplaceability in terms of use for the amplification of a small segment of DNA.
Based on application, Oncology is expected to be the most lucrative segment. This is due to an increase in cancer prevalence around the world, as well as a surge in demand for personalized therapy and the use of pharmacogenomics in drug discovery and development.
Based on region, North America is expected to be the most lucrative region. This is due to significant investments in medical research and development.
Inquire for Regional Data: https://reports.valuates.com/request/regional/QYRE-Auto-22U5750/Global_Pharmacogenomics_PGx_Market
Key Companies:
- Abbott Laboratories
- Affymetrix, Inc.
- Assurex Health, Inc
- Astrazeneca
- GeneDX
- Illumina, Inc.
- Laboratory Corporation of America Holdings
- Myriad Genetics, Inc.
- Pathway Genomics
- Pfizer, Inc
- Qiagen, Inc.
- Rocheg
- Teva Pharmaceutical Industries Ltd.
- Thermo Fisher Scientific
- Transgenomic, Inc.
Inquire for Chapter Cost: https://reports.valuates.com/request/chaptercost/QYRE-Auto-22U5750/Global_Pharmacogenomics_PGx
Buy Now for Single User + Covid-19 Impact :https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-22U5750&lic=single
SUBSCRIPTION
We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.
SIMILAR REPORTS:
- The global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market size is projected to reach USD 8514.8 Million by 2028, from USD 5180.8 Million in 2021, at a CAGR of 6.9% during 2022-2028.
- The global Pharmacovigilance market size is projected to reach USD 7778 Million by 2027, from USD 4385.7 Million in 2020, at a CAGR of 8.1% during 2021-2027.
- The global Precision Medicine market size is projected to reach USD 206320 Million by 2027, from USD 104940 Million in 2020, at a CAGR of 9.6% during 2021-2027.
- The genetic testing market accounted for USD 12,682 Million in 2019, and is expected to reach USD 21,260 Million by 2027, registering a CAGR of 10.1% from 2020 to 2027.
- The global tissue engineering market size was valued at USD 2374 Million in 2019 and is forecasted to reach a size of USD 6815 Million by 2027 at a CAGR of 14.2% from 2020 to 2027.
- The global metabolomics market size was valued at USD 2,032 Million in 2020, and is projected to reach USD 6,663 Million by 2030, registering a CAGR of 12.2% from 2021 to 2030.
- Due to the COVID-19 pandemic, the global Organ-on-a-Chip market size is estimated to be worth USD 80 Million in 2022 and is forecast to a readjusted size of USD 581.2 Million by 2028 with a CAGR of 39.1% during the review period.
- The global cell therapy market accounted for USD 7,754.89 Million in 2019, and is expected to reach USD 48,115.40 Million by 2027, registering a CAGR of 25.6% from 2020 to 2027.
- The Global Bioinformatics Market Size is USD 8,614.29 Million in 2019, and is projected to reach USD 24,731.61 Million by 2027, growing at a CAGR of 13.4% from 2020 to 2027.
- The global Single-Cell Analysis market was valued at USD 3165.2 Million in 2022 and is projected to reach USD 7656.8 million by 2028, registering a CAGR of 13.2% from 2022 to 2028.
- The global cell culture market accounted for USD 16,107.7 Million in 2019 and is expected to reach USD 36,926.8 Million by 2027, registering a CAGR of 10.9% from 2020 to 2027.
- The global Genomics market size is projected to reach USD 31240 Million by 2027, from USD 15120 Million in 2020, at a CAGR of 10.8% during 2021-2027.
- The global Bioinformatics Services market size is projected to reach USD 2967.1 Million by 2027, from USD 1468.2 Million in 2020, at a CAGR of 10.1% during 2021-2027.
- The Live Cell Imaging Market is anticipated to grow at the rate of 8.9% CAGR by 2027.
Click here to see related reports on Pharmacogenomics Market
ABOUT US:
Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.
Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.
To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.
CONTACT US:
Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
LinkedIn - https://in.linkedin.com/company/valuatesreports
Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg
